NCT01140256

Brief Summary

Large-scale zinc supplementation studies have demonstrated highly significant positive effects on growth, morbidity and mortality in infants who are born small for gestational age (SGA). This suggests these infants may have higher postnatal requirements compared to appropriate for gestational age (AGA) infants, possibly due to inadequate zinc intake from breast milk due either to lower volume or to differences in milk zinc concentrations from mothers of SGA compared to AGA infants. Alternatively, SGA infants may have lower zinc stores at birth, which may reflect a greater postnatal requirement for optimal zinc status. It is thus possible that the zinc requirements of the SGA infant exceed the zinc intake that can be achieved from exclusive breastfeeding, which is recommended for the first 6 mo of life. The exchangeable zinc pool (EZP) is defined as the estimate of the total size of the combined pools of zinc that exchange with zinc in plasma within approximately 2-3 days and may also differ between SGA and AGA infants.

  1. 1.Compare longitudinal zinc intake by measuring milk zinc concentrations and volume of intake of breast milk between SGA and AGA infants through first 12 mo.
  2. 2.Compare post-natal growth rates for SGA and AGA infants through the first 12 mo of life in relation to zinc intake.
  3. 3.Compare size of exchangeable zinc pool (EZP) at birth and at 6 mo of age between SGA and AGA infants.
  4. 4.Zinc concentrations in human milk will not be significantly different at any stage of lactation between mothers of SGA infants and mothers of AGA infants.
  5. 5.The volume of breast milk intake relative to body weight will be similar between SGA and AGA infants, but the total intake will be lower in SGA infants.
  6. 6.Linear growth rates, rate of weight gain, and rate of growth in head circumference will be significantly lower in infants born SGA, and will be positively correlated with total daily zinc intake.
  7. 7.The size of the EZP at birth will be significantly smaller in absolute size and relative to body weight in infants born SGA compared to AGA

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2007

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2007

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2009

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

June 8, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 9, 2010

Completed
Last Updated

June 9, 2010

Status Verified

July 1, 2009

First QC Date

June 8, 2010

Last Update Submit

June 8, 2010

Conditions

Keywords

ZincSGAAGAstable isotope

Outcome Measures

Primary Outcomes (1)

  • To Compare size of exchangeable zinc pool (EZP) at birth and at 6 mo of age between SGA and AGA infants

    We measured the exchangeable zinc pool sizes in exclusively breast fed infants at birth and then at 6 months of age among the SGA and AGA infants by zinc stable isotope technique.Intravenous dose of pre measured was administered.Urine was collected and analyzed for enrichemnt of zinc isotope.The entire procedure was repeated at 6 months.

Study Arms (3)

SGA infants

SGA infants were recruited at birth and zinc stable isotope was administered at birth and at 6 months of age .This was a longitudinal study whereby the growth trajectory and zinc pools were measured.

AGA

AGA infants were recruited at birth and zinc stable isotope was administered at birth and at 6 months of age .This was a longitudinal study whereby the growth trajectory and zinc pools were measured.

SGA infant

Infants who were born small for gestational age were recruited and zinc stable isotopes were administered at birth and at 6 months.

Eligibility Criteria

AgeUp to 48 Hours
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

SGA and AGA infants born to healthy mothers.

You may qualify if:

  • Mothers: Healthy women 18-40 yr; primips or multips; Infants: Healthy at birth

You may not qualify if:

  • Mothers: tobacco or alcohol use during pregnancy; HIV or chronic infection such as TB.
  • Infants: twins/multiples; congenital infections, malformations; gestational age \< 37 wk ; severe anemia at birth.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aga Khan university

Karachi, Sindh, 74800, Pakistan

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 8, 2010

First Posted

June 9, 2010

Study Start

January 1, 2007

Study Completion

July 1, 2009

Last Updated

June 9, 2010

Record last verified: 2009-07

Locations